News & Events

01

Mar2023

INESSS Fee Schedule Update; Upcoming CADTH Consultation and Application Process Updates

/ CADTH, INESSS, News
INESSS has published its updated fee schedule for its scientific evaluation of drugs, stable blood products and technologies in the February 18, 2023 Gazette du Québec. Fees for all submission types have increased 6.44% as of January 1, 2023, bringing fees to: $63,791 for a new ... Read More

24

Feb2023

Doug Clark Resigns from PMPRB

/ News, PMPRB
On February 24, 2023, Doug Clark announced he is stepping down from his position as Executive Director of the PMPRB after almost a decade with PMPRB. Clark will continue to serve as a special advisor to the Board as he transitions to retirement from the federal public service. ... Read More

24

Feb2023

PMPRB Board Member Resigns

/ News, PMPRB
On February 23, 2023, Matthew Herder, a PMPRB Board Member since 2018, publicly announced his resignation from the PMPRB. He shared his resignation letter on his personal twitter page today. The letter, which he notes was submitted to Health Minister Jean-Yves Duclos on Monday, outlines his reasons for parting ways with ... Read More

13

Feb2023

PMPRB New Chairperson

/ News, PMPRB
On Wednesday, February 1, 2023, the Minister of Health announced the appointment of Thomas J Digby as the new Chairperson for the PMPRB. This nomination comes after over a year of being vacant when Dr. Mitchell Levine completed his five-year term tenure on November 2021. Thomas J. Digby ... Read More

13

Feb2023

 pCPA Recruiting Their First CEO

/ News, pCPA
On February 3, 2023, pCPA Office announced a major step in its transition to a stand-alone organization: the recruitment of a chief executive officer (CEO). The new CEO is expected to be in place by Spring 2023. This announcement is a crucial part of the organizational review conducted in ... Read More

20

Dec2022

Updates to the Quebec Guidelines for Drug Submission and Evaluation

/ INESSS, News, Quebec
The Institut national d’excellence en Santé et en services sociaux (INESSS) has recently updated the Guidance Document for Submitting a Request to INESSS and affiliate documents. This document consolidates updates previously communicated through manufacturer notices and replaces the 2018 version of the guidelines.  ... Read More

19

Dec2022

PMPRB Interim Chairperson Confirms Resignation

/ News, PMPRB
Mélanie Bourassa Forcier, Vice-Chairperson and Acting Chairperson of the Patented Medicine Prices Review Board (PMPRB), confirmed her resignation from the Board on Twitter on December 7, 2022. In her comment she indicated she is evaluating her legal obligations concerning whether she can share the reasons for her ... Read More

05

Dec2022

PMPRB’s 2021 Annual Report Shows Worrying Decline in Number of New Medicines Launched in Canada; HDAP Meeting Tentatively Scheduled for Spring 2023

/ News, PMPRB
Last week the Patented Medicine Prices Review Board (PMPRB) presented its 2021 Annual Report  to Federal Health Minister Duclos in accordance with its reporting mandate outlined in sections 89 and 100 of the Patent Act. Key statistics reinforce concerns about Canada’s continued attractiveness for new medicine launch ... Read More

05

Dec2022

PDCI Well Wishes for Managing Director Kaitlyn Proulx

/ News, PDCI
PDCI is congratulating its Managing Director, Kaitlyn Proulx, as she begins parental leave effective November 28, 2022.Since joining PDCI in 2010, Kaitlyn has demonstrated incredible strategic insights advising clients on optimizing pricing and market access in Canada. Since becoming Managing Director in 2017, Kaitlyn has ... Read More

05

Dec2022

CADTH Pharmaceutical Reviews Update Includes Launch of RWE Guidance Consultation

/ CADTH, News
On November 10, 2022, among other procedural updates included in the CADTH Pharmaceutical Reviews Update Issue 32, CADTH published its Real-World Evidence (RWE) Steering Committee’s anticipated Proposed RWE Reporting Guidance and initiated a public consultation on the guidance open now through January 6, 2023.What to know: The ... Read More